Related references
Note: Only part of the references are listed.Arginase Inhibitors: A Rational Approach Over One Century
Marc Pudlo et al.
MEDICINAL RESEARCH REVIEWS (2017)
Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature
Charles F. Craddock et al.
CLINICAL CANCER RESEARCH (2017)
Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia
Qifang Zhang et al.
BLOOD (2016)
DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer
Krista P. Terracina et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
Roger Geiger et al.
CELL (2016)
Molecular basis and current strategies of therapeutic arginine depletion for cancer
Livingstone Fultang et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
MAGE-C2-Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell Responses
Andre Kunert et al.
JOURNAL OF IMMUNOLOGY (2016)
Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target
Francis Mussai et al.
BLOOD (2015)
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
Herve Dombret et al.
BLOOD (2015)
Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity
Francis Mussai et al.
CANCER RESEARCH (2015)
CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia
S. S. Kenderian et al.
LEUKEMIA (2015)
Treatment of CD33-directed Chimeric Antigen Receptor-modified T Cells in One Patient With Relapsed and Refractory Acute Myeloid Leukemia
Quan-shun Wang et al.
MOLECULAR THERAPY (2015)
Transcriptional Regulation of Endothelial Arginase 2 by Histone Deacetylase 2
Deepesh Pandey et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses
Benjamin Uttenthal et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer
Kunle Odunsi et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment
Francis Mussai et al.
BLOOD (2013)
Polyphenol E Enhances the Antitumor Immune Response in Neuroblastoma by Inactivating Myeloid Suppressor Cells
Giorgia Santilli et al.
CLINICAL CANCER RESEARCH (2013)
Phase II Trial of Vorinostat With Idarubicin and Cytarabine for Patients With Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Guillermo Garcia-Manero et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia
Djordje Atanackovic et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia
Oliver Goodyear et al.
BLOOD (2010)
CD8+ T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effect
Andrew McLarnon et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches
Jochen Greiner et al.
BLOOD (2006)
The spermatozoa protein, SLLP1, is a novel cancer-testis antigen in hematologic malignancies
ZQ Wang et al.
CLINICAL CANCER RESEARCH (2004)
Differences in T-cell immunity toward tumor-associated antigens in colorectal cancer and breast cancer patients
D Nagorsen et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Share Paper
